Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH

SI-6183

Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH, >98% (HPLC)

CAS No. : [2750350-39-9]

IUPAC Name : 2-(3-((3'-(((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-5'-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4'-methyl-[1,1'-biphenyl]-4-yl)oxy)propoxy)acetic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Tazemetostat de(methylene morpholine)‑O‑C3‑O‑C‑COOH derivative of Tazemetostat, contains both an EZH2‑targeting warhead and a PROTAC linker for E3 ligase recruitment. It serves as a modular precursor for synthesizing EZH2 degraders used in lymphoma research.

References : Tu Y. et al.: J. Med. Chem., 64(14), 10167-10184, 2021.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.